Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Palomaki

Showing results (81-90 of 275) with videos related to

Pageof 28
Sort By:
Obstetrics and Gynecology|December 1, 1991
Self-rated physical activity level during the second trimester and pregnancy outcomeN C Rose, J E Haddow, G E Palomaki, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2014
Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveysLaura J Tafe, Michael B Datto, Glenn E Palomaki, et al.
Prenatal Diagnosis|November 1, 1990
Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifidaJ A Canick, G J Knight, G E Palomaki, et al.
Annals of Clinical and Laboratory Science|October 19, 2022
Surveillance of SARS-CoV-2 Antibodies in Early 2020 among Rhode Island PregnanciesErica J Hardy, Glenn E Palomaki, C James Sung, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 1, 2014
Comparison of radiographic femur measurements in stillbirths and neonatal deaths to ultrasound measurements in ongoing pregnanciesHalit Pinar, Glenn E Palomaki, Hamish R M Haddow, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2012
Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based reviewLinda A Bradley, Glenn E Palomaki, Jessica Bienstock, et al.
Journal of Medical Screening|January 1, 1996
Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancyG M Lambert-Messerlian, J A Canick, G E Palomaki, et al.
Clinical Chemistry|September 14, 2022
Assessment of a Simplified Cell-Free DNA Method for Prenatal Down Syndrome ScreeningGlenn E Palomaki, Elizabeth E Eklund, Edward M Kloza, et al.
Journal of Medical Screening|August 1, 2017
Measuring maternal serum screening markers for Down's syndrome in plasma collected for cell-free DNA testingGeralyn M Lambert-Messerlian, Elizabeth E Eklund, Louis M Neveux, et al.
Prenatal Diagnosis|May 14, 2015
Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive proceduresGlenn E Palomaki, Elizabeth E Eklund, Louis M Neveux, et al.
Pageof 28

Showing results (81-90 of 275) with videos related to

Sort By:
Pageof 28
Obstetrics and Gynecology|December 1, 1991
Self-rated physical activity level during the second trimester and pregnancy outcomeN C Rose, J E Haddow, G E Palomaki, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2014
Molecular testing for the BRCA1 and BRCA2 Ashkenazi Jewish founder mutations: a report on the College of American Pathologists proficiency testing surveysLaura J Tafe, Michael B Datto, Glenn E Palomaki, et al.
Prenatal Diagnosis|November 1, 1990
Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifidaJ A Canick, G J Knight, G E Palomaki, et al.
Annals of Clinical and Laboratory Science|October 19, 2022
Surveillance of SARS-CoV-2 Antibodies in Early 2020 among Rhode Island PregnanciesErica J Hardy, Glenn E Palomaki, C James Sung, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 1, 2014
Comparison of radiographic femur measurements in stillbirths and neonatal deaths to ultrasound measurements in ongoing pregnanciesHalit Pinar, Glenn E Palomaki, Hamish R M Haddow, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2012
Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based reviewLinda A Bradley, Glenn E Palomaki, Jessica Bienstock, et al.
Journal of Medical Screening|January 1, 1996
Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancyG M Lambert-Messerlian, J A Canick, G E Palomaki, et al.
Clinical Chemistry|September 14, 2022
Assessment of a Simplified Cell-Free DNA Method for Prenatal Down Syndrome ScreeningGlenn E Palomaki, Elizabeth E Eklund, Edward M Kloza, et al.
Journal of Medical Screening|August 1, 2017
Measuring maternal serum screening markers for Down's syndrome in plasma collected for cell-free DNA testingGeralyn M Lambert-Messerlian, Elizabeth E Eklund, Louis M Neveux, et al.
Prenatal Diagnosis|May 14, 2015
Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive proceduresGlenn E Palomaki, Elizabeth E Eklund, Louis M Neveux, et al.
Pageof 28